Triflex Sport Tablets
Natural health product licensed in Canada
- Licence holder
- GNC Canada Holdings ULC
- NPN or DIN-HM
- 80031168
- Status
- Inactive licence
- Licence date
- 30 March 2012
- Revision date
- 3 June 2015
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Salix alba Source : Écorce Extraction ratio : 14:1 Dry plant equivalent : 2,800 mg Potency : 15 % Salicin | 200 mg | Not calculated |
| Humulus lupulus Source : Strobiles Extraction ratio : 2:1 Dry plant equivalent : 83.34 mg Potency : 30 % Alpha & Iso-Alpha Acids | 41.67 mg | Not calculated |
| Acide hyaluronique Source : Sodium hyaluronate from bacterial extracellular capsule of Streptococcus equi | 1.25 mg | Not calculated |
Non-medicinal ingredients
Ethyl Vanillin, (p)-hydroxybenzoate de propyle, Dioxyde de titane, Calcium silicate, Croscarmellose de sodium, Hypromellose, (p)-hydroxybenzoate de méthyle, Saveur de vanille, Microcrystalline cellulose, Poly(éthylène glycol), Acétoglycérides, Hydroxypropylcellulose, Poly(sorbate) 80, Stéarate de magnésium, Couleur caramel, Crospovidone, Sucralose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. A factor in maintaining healthy cartilage. Helps to maintain healthy cartilage. A factor in maintaing joint health. Helps to maintain joint health. Helps in the development and maintenance of bones and cartilage. Helps in connective tissue formation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80031168
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2015. Photograph the packaging to check whether it has changed. Photograph the packaging